GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Huapont Life Science Co Ltd (SZSE:002004) » Definitions » Capex-to-Operating-Cash-Flow

Huapont Life Science Co (SZSE:002004) Capex-to-Operating-Cash-Flow : 3.54 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Huapont Life Science Co Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Huapont Life Science Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-395.04 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was ¥111.52 Mil.

Hence, Huapont Life Science Co's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2024 was 3.54.


Huapont Life Science Co Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Huapont Life Science Co's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huapont Life Science Co Capex-to-Operating-Cash-Flow Chart

Huapont Life Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.52 0.99 0.47 0.81

Huapont Life Science Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.23 0.41 0.59 3.54

Competitive Comparison of Huapont Life Science Co's Capex-to-Operating-Cash-Flow

For the Agricultural Inputs subindustry, Huapont Life Science Co's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huapont Life Science Co's Capex-to-Operating-Cash-Flow Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Huapont Life Science Co's Capex-to-Operating-Cash-Flow falls into.



Huapont Life Science Co Capex-to-Operating-Cash-Flow Calculation

Huapont Life Science Co's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-1284.122) / 1589.477
=0.81

Huapont Life Science Co's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-395.035) / 111.518
=3.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huapont Life Science Co  (SZSE:002004) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Huapont Life Science Co Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Huapont Life Science Co's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Huapont Life Science Co (SZSE:002004) Business Description

Traded in Other Exchanges
N/A
Address
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
Executives
Zhang Hai An Directors, executives
Wang Rong Director
Yu Jun Tian Director
Zhang Song Shan Directors, executives
Chen Zhi Securities Affairs Representative
Jiang Kang Wei Director
Lv Li Ming Director
Li Sheng Xue Director
Luo Da Lin Supervisors
Li Zhi Directors, executives
Tian Song Min Executives
Wu Bi Zhong Director
Yu Yun Jian Supervisors
Gu Chuan Wei Supervisors

Huapont Life Science Co (SZSE:002004) Headlines

No Headlines